New president/CEO announces timely goals for established foundation
WHITE PLAINS, N.Y., March 2 /PRNewswire/ -- Several high-profile cancers are infamous for being silent killers - but they are not the only cancers that catch victims by surprise. Carcinoid cancer can go undetected for many years. Over 90% of all carcinoid/neuroendocrine tumor (NET) patients are initially incorrectly diagnosed and treated for the wrong disease. Carcinoid cancers are frequently diagnosed accidentally.
Carcinoid and related neuroendocrine tumors (NETs) grow slowly and are found mostly in the gastrointestinal system, but can be in other body parts like the pancreas and lung. It usually takes many years before they cause symptoms. If the disease manifests in advanced stages, it can be deadly. Caught early, however, carcinoid cancer can often be managed or treated, an option not fully realized within the medical community or patient circles, according to Sharon Devereaux, the newly appointed president/CEO of the Carcinoid Cancer Foundation(TM) (CCF, http://www.carcinoid.org). Increasing awareness of this disease and opportunities for early detection are an integral part of the Carcinoid Cancer Foundation's mission, and Devereaux's initiatives include intensification of efforts to accomplish these goals.
"Carcinoid cancer occasionally creeps into the headlines, usually when some public figure is living with it or passes away," Devereaux says. "But that's where the news value ends because it's perceived as rare - 110,000 U.S. patients are experiencing carcinoid cancer today. However, new research and anecdotal evidence suggests that it's more widespread than is documented, yet it's tough to provide treatment because established opportunities for early-diagnostic testing don't exist."
Richard R.P. Warner, MD, Medical Director of CCF and one of the world's leading
'/>"/>
| SOURCE Carcinoid Cancer Foundation Copyright©2009 PR Newswire. All rights reserved |